Recombinant Activated Factor VII: The Controversial Conundrum Regarding Its Off-Label Use

被引：14
|
作者：
Karkouti, Keyvan [1 ]
Levy, Jerrold H. [2 ]
机构：
[1] Univ Toronto, Univ Hlth Network, Toronto Gen Hosp, Dept Anesthesiol & Hlth Policy Management & Evalu, Toronto, ON M5G 2C4, Canada
[2] Emory Univ, Dept Anesthesiol, Sch Med Cardiothorac Anesthesiol & Crit Care Emor, Atlanta, GA 30322 USA
来源：
ANESTHESIA AND ANALGESIA | 2011年 / 113卷 / 04期
关键词：
CARDIAC-SURGERY; HEALTHY-SUBJECTS; REVERSAL; WARFARIN; SAFETY; RFVIIA;
D O I：
10.1213/ANE.0b013e318228c6a9
中图分类号：
R614 [麻醉学];
学科分类号：
100217 ;
摘要：
引用
收藏
页码：711 / 712
页数：2
相关论文
共 50 条
  • [1] Off-Label Use of Recombinant Activated Factor VII -- Safe or Not Safe?.
    Aledort, Louis M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (19): : 1853 - 1854
  • [2] Off-label use of recombinant activated factor VII (rFVIIa) in children.
    Punzalan, RC
    Ghanayem, NS
    Gill, JC
    Jaquiss, RDB
    Montgomery, RR
    Gottschall, JL
    BLOOD, 2003, 102 (11) : 137B - 137B
  • [3] Off-label Use of Recombinant Activated Factor VII for Cardiac Surgical Bleeding
    Flynn, Brigid C.
    Steiner, Marie E.
    Mazzeffi, Michael
    ANESTHESIOLOGY, 2023, 139 (02) : 197 - 210
  • [4] SAFETY AND EFFICACY OF OFF-LABEL USE OF RECOMBINANT ACTIVATED FACTOR VII IN CARDIOTHORACIC SURGERY
    Walla, Danielle
    Johnson, Manda
    Baek, Grace
    Schanz, Caitlin
    Pham, Lily
    CRITICAL CARE MEDICINE, 2020, 48
  • [5] Comprehensive Canadian review of the off-label use of recombinant activated factor VII in cardiac surgery
    Karkouti, Keyvan
    Beattie, W. Scott
    Arellano, Ramiro
    Aye, Tim
    Bussieres, Jean S.
    Callum, Jeannie L.
    Cheng, Davy
    Heinrich, Lee
    Kent, Blaine
    Lee, Trevor W. R.
    MacAdams, Charles
    Mazer, C. David
    Muirhead, Brian
    Rochon, Antoine G.
    Rubens, Fraser D.
    Sawchuk, Corey
    Wang, Shaohua
    Waters, Terrence
    Wong, Bill I.
    Yau, Terrence M.
    CIRCULATION, 2008, 118 (04) : 331 - 338
  • [6] Review of the Off-Label Use of Recombinant Activated Factor VII in Pediatric Cardiac Surgery Patients
    Guzzetta, Nina A.
    Russell, Isobel A.
    Williams, Glyn D.
    ANESTHESIA AND ANALGESIA, 2012, 115 (02): : 364 - 378
  • [7] Off-label use of recombinant activated factor VII in hemophagocytic lymphohistiocytosis patients with major bleeding
    You, Yahong
    Suolitiken, Dina
    Wu, Lin
    Pi, Yubo
    Chen, Leilei
    Song, Deli
    Song, Zhengyang
    Wang, Zhao
    Wang, Jingshi
    LEUKEMIA & LYMPHOMA, 2025,
  • [8] Evaluation of off-label recombinant activated factor VII for multiple indications in children
    Reiter, Pamela D.
    Valuck, Robert J.
    Taylor, Rustorl S.
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2007, 13 (03) : 233 - 240
  • [9] Emerging off-label uses for recombinant activated factor VII: Grading the evidence
    Enomoto, TM
    Thorborg, P
    CRITICAL CARE CLINICS, 2005, 21 (03) : 611 - +
  • [10] Use of Low-Dose Recombinant Activated Factor VII in the Off-Label Setting: A Comment to "The Judicious Use of Recombinant Factor VIIa"
    Kubisz, Peter
    Stasko, Jan
    Holly, Pavol
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2017, 43 (03): : 355 - 356
12345